Please use this identifier to cite or link to this item: http://hdl.handle.net/10637/14991

Neurodegenerative Proteinopathies Induced by Environmental Pollutants: Heat Shock Proteins and Proteasome as Promising Therapeutic Tools


Thumbnail

See/Open:
 Neurodegenerative_Moyano_et_al_Pharm_2023.pdf
  Restricted Access

2,53 MB
Adobe PDF
 Request a copy
Title: Neurodegenerative Proteinopathies Induced by Environmental Pollutants: Heat Shock Proteins and Proteasome as Promising Therapeutic Tools
Authors : Moyano, Paula
Sola, Emma
Naval, Victoria
Guerra Menéndez, Lucía
Cabeza Fernández, María de la
Pino, Javier del
Keywords: Environmental PollutantsHeat Shock ProteinsProteasomeProteinopathiesNeurodegenerative Diseases
Publisher: MDPI
Citation: Moyano, P.; Sola, E.; Naval, M.V.; Guerra-Menéndez, L.; Fernández, M.D.l.C.; del Pino, J. Neurodegenerative Proteinopathies Induced by Environmental Pollutants: Heat Shock Proteins and Proteasome as Promising Therapeutic Tools. Pharmaceutics 2023, 15, 2048. https://doi.org/10.3390/ pharmaceutics15082048
Abstract: Environmental pollutants’ (EPs) amount and diversity have increased in recent years due to anthropogenic activity. Several neurodegenerative diseases (NDs) are theorized to be related to EPs, as their incidence has increased in a similar way to human EPs exposure and they reproduce the main ND hallmarks. EPs induce several neurotoxic effects, including accumulation and gradual deposition of misfolded toxic proteins, producing neuronal malfunction and cell death. Cells possess different mechanisms to eliminate these toxic proteins, including heat shock proteins (HSPs) and the proteasome system. The accumulation and deleterious effects of toxic proteins are induced through HSPs and disruption of proteasome proteins’ homeostatic function by exposure to EPs. A therapeutic approach has been proposed to reduce accumulation of toxic proteins through treatment with recombinant HSPs/proteasome or the use of compounds that increase their expression or activity. Our aim is to review the current literature on NDs related to EP exposure and their relationship with the disruption of the proteasome system and HSPs, as well as to discuss the toxic effects of dysfunction of HSPs and proteasome and the contradictory effects described in the literature. Lastly, we cover the therapeutic use of developed drugs and recombinant proteasome/HSPs to eliminate toxic proteins and prevent/treat EP-induced neurodegeneration.
URI: http://hdl.handle.net/10637/14991
Rights : http://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
OpenAccess
ISSN: 1999-4923
Issue Date: 30-Jul-2023
Center : Universidad San Pablo-CEU
Appears in Collections:Medicina





Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.